Additionally, GLP-1 activates related intracellular signaling pathways, promoting -cell regeneration, inhibiting -cell apoptosis, and improving -cell function, thereby lowering blood glucose levels, with its effects being glucose concentration-dependent (58, 59)
quantity limits differ based on whether the patient uses insulin, regardless of Type 1 or Type 2 classification
7 The research opportunity connecting claims with real-world data The opportunity for manufacturers, researchers, and healthcare stakeholders is to bridge this data gap and gain a comprehensive view of the GLP-1 obesity treatment journey
PlexusDx partners with established 503A providers to ensure consistent availability, transparent pricing across commitment tiers, and quality assurance without the supply vulnerabilities affecting branded products